Rankin Aubrey

President, Innovation & Tech at Revance Therapeutics, Inc.

Sold, on record
$8.7M
Dollars the filings state
Form 4 sales
10
Latest Aug 16, 2021
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale Revance Therapeutics, Inc.Plan not stated
    Nov 30, 2020 2020

    Sold 33,119 shares at $23.85 ($790k)

    Rankin Aubrey, President, Innovation & Tech

    Sold 6.1% of holdings ($13M position)510,684 shares leftFiling

  2. 2 Form 4 sale Revance Therapeutics, Inc.Plan not stated
    Dec 30, 2020 +30 days

    Sold 33,119 shares at $27.82 ($921k)

    Rankin Aubrey, President, Innovation & Tech

    Sold 6.5% of holdings ($14.2M position)477,565 shares left1x usual sizeFiling

  3. 3 Form 4 sale Revance Therapeutics, Inc.Plan not stated
    Feb 1, 2021 +33 days

    Sold 33,119 shares at $25.95 ($859k)

    Rankin Aubrey, President, Innovation & Tech

    Sold 6.9% of holdings ($12.4M position)444,446 shares left1x usual sizeFiling

  4. 4 Form 4 sale Revance Therapeutics, Inc.Plan not stated
    Mar 4, 2021 +31 days

    Sold 33,119 shares at $25.43 ($842k)

    Rankin Aubrey, President, Innovation & Tech

    Sold 7.5% of holdings ($11.3M position)411,327 shares left1x usual sizeFiling

  5. 5 Form 4 sale Revance Therapeutics, Inc.Plan not stated
    Apr 5, 2021 +32 days

    Sold 2 shares at $28.28 ($57)

    Rankin Aubrey, President, Innovation & Tech

    Sold 0% of holdings ($11.6M position)411,325 shares left0x usual sizeFiling

  6. 6 Form 4 sale Revance Therapeutics, Inc.Plan not stated
    Jul 26, 2021 +112 days

    Sold 55,382 shares at $29.72 ($1.6M)

    Rankin Aubrey, President, Innovation & Tech

    Sold 13.5% of holdings ($12.2M position)355,943 shares left1.7x usual sizeFiling

  7. 7 Form 4 sale Revance Therapeutics, Inc.Unusual
    Jul 28, 2021 +2 days

    Sold 54,332 shares at $30.06 ($1.6M)

    Rankin Aubrey, President, Innovation & Tech

    Sold 26% of holdings ($6.3M position)154,302 shares left1.6x usual sizeFiling

  8. 8 Form 4 sale Revance Therapeutics, Inc.Plan not stated
    Aug 16, 2021 +19 days

    Sold 9,364 shares at $26.34 ($247k)

    Rankin Aubrey, President, Innovation & Tech

    Sold 12.5% of holdings ($2M position)65,463 shares left0.3x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (10)

Form 144 notices and Form 4 sales by Rankin Aubrey
Source
Aug 16, 2021Aug 17, 2021Revance Therapeutics, Inc.President, Innovation & TechForm 4 sale9,364$247k12.5%Plan not statedSEC
Jul 28, 2021Jul 30, 2021Revance Therapeutics, Inc.President, Innovation & TechForm 4 sale54,332$1.6M26.0%UnusualSEC
Jul 26, 2021Jul 28, 2021Revance Therapeutics, Inc.President, Innovation & TechForm 4 sale55,382$1.6M13.5%Plan not statedSEC
Apr 5, 2021Apr 6, 2021Revance Therapeutics, Inc.President, Innovation & TechForm 4 sale2$570.0%Plan not statedSEC
Mar 4, 2021Mar 5, 2021Revance Therapeutics, Inc.President, Innovation & TechForm 4 sale33,119$842k7.5%Plan not statedSEC
Feb 1, 2021Feb 3, 2021Revance Therapeutics, Inc.President, Innovation & TechForm 4 sale33,119$859k6.9%Plan not statedSEC
Dec 30, 2020Jan 4, 2021Revance Therapeutics, Inc.President, Innovation & TechForm 4 sale33,119$921k6.5%Plan not statedSEC
Nov 30, 2020Dec 2, 2020Revance Therapeutics, Inc.President, Innovation & TechForm 4 sale33,119$790k6.1%Plan not statedSEC
Oct 29, 2020Oct 30, 2020Revance Therapeutics, Inc.President, Innovation & TechForm 4 sale33,119$866k5.7%Plan not statedSEC
Sep 28, 2020Sep 30, 2020Revance Therapeutics, Inc.President, Innovation & TechForm 4 sale33,119$867k5.4%Plan not statedSEC